Skip to main content
. Author manuscript; available in PMC: 2022 Jun 22.
Published in final edited form as: Int J Gynaecol Obstet. 2018 Nov 20;144(2):180–186. doi: 10.1002/ijgo.12703

TABLE 5.

Performance of the AmnioQuick Duo+and PAMG-1 tests for diagnosis of prolonged PROM by gestational age at presentation.

Performance evaluator AmnioQuick Duo+ PAMG-1
Gestational age <34 wk
 No. of true negatives 11 11
 No. of true positives 31 28
 No. of false negatives 1 4
 No. of false positives 0 0
 Total no. 43 43
 Specificity, % (95% CI) 100 (67.9–100) 100 (67.9–100)
 Sensitivity, % (95% CI) 96.9 (82.0–99.8) 87.5 (70.1–95.9)
 NPV, % (95% CI) 91.7 (59.8–99.6) 73.3 (44.8–91.1)
 PPV, % (95% CI) 100 (86.3–100) 100 (85.0–100)
 Accuracy, % (95% CI)a 97.7 (82.5–99.9) 90.7 (72.8–97.9)
Gestational age ≥34 wk
 No. of true negatives 13 13
 No. of true positives 42 42
 No. of false negatives 1 1
 No. of false positives 0 0
 Total no. 56 56
 Specificity, % (95% CI) 100 (71.7–100) 100 (71.7–100)
 Sensitivity, % (95% CI) 97.7 (86.2–99.9) 96.6 (86.2–99.9)
 NPV, % (95% CI) 92.9 (64.2–99.6) 92.9 (64.2–99.6)
 PPV, % (95% CI) 100 (89.6–100) 100 (89.6–100)
 Accuracy, % (95% CI)b 98.2 (88.4–99.9) 98.2 (88.4–99.9)

Abbreviations: CI, confidence interval; NPV, negative predictive value; PAMG-1, placental α-microglobulin-1; PPV, positive predictive value; PROM, premature rupture of membranes.

a

Among women presenting with prolonged PROM <34 wk, the AmnioQuick Duo+ accuracy of 97.7% was not statistically different to the PAMG-1 test accuracy of 90.7% (Pearson χ2=0.180, P=0.360; relative risk 2.59, 95% CI 0.40–217.09).

b

Similarly, among women presenting with PROM at ≥34 wk, the AmnioQuick Duo+ accuracy of 98.2% was not statistically different to the PAMG-1 test accuracy of 98.2% (Pearson χ2=0.712, P>0.99; relative risk 1.00, 95% CI 0.25–4.05).